Check out what we have in store for you in the August Newsletter
In this month’s Eblast we have a lot of information to pass on to you. At the top of the list is that a new combination of hepatitis C medications was approved by the Food and Drug Administration (FDA) to re-treat people who have not been cured with a previous course of certain direct-acting antiviral medications. You can read about it in this month’s HCV Advocate newsletter.
This month’s newsletter includes:
- HCV SnapShots by Alan Franciscus includes HCV Drugs that offers a short overview of the FDA approval of Vosevi listed above. There is also a comprehensive overview of Vosevi that can be found on our Hep C Medications Blog at http://hepatitiscmedications.hcvadvocate.org/vosevii/. It is also expected that AbbVie’s Maviret will be approved by the FDA in August.
In SnapShots I report on two studies 1) examination of acute kidney disease in a sofosbuvir-based treatment study, and 2) an analysis comparing the adherence of people who inject drugs vs. those who don’t inject drugs.
- Healthwise by Lucinda K. Porter—Life After Hepatitis C-Lucinda provides valuable information about moving on after being cured of hepatitis C and provides opinions from some of the leading experts on liver disease.
- Hepatitis C in Children by Alan Franciscus—I provide an overview of hepatitis C in children including the prevalence, transmission from mother–to-child, testing children, transmission among children, disease progression and monitoring, and treatment with direct-acting antiviral medications.
- Under the Umbrella by Matthew Zielske—Matthew discusses the HCSP Train-the-Trainer workshops he conducts and the concerns that the workshop attendees experience in their daily work trying to combat the opiate epidemic sweeping the country.
- What’s Up!
Check out five new Harm Reduction fact sheets:
Lastly, we found a glitch in our website email system. If you sent an email to us and you never received a response it is likely that it was one of the automatic email systems that was broken. The problem has been fixed and the system is working correctly. If you still need information feel free to email me at email@example.com.
Peace, prosperity and good health,
Alan and the dedicated people from the HCV Advocate